Selling Comparative Effectiveness: Practice May Need Positive Branding
This article was originally published in The Gray Sheet
With the national infrastructure for comparative effectiveness research set to expand, the government should be thinking about how to get out a positive message about the oft-maligned practice, policy experts say
You may also be interested in...
Mammography coverage policies among public and private payers are not likely to be restricted, at least in the near term, by the U.S. Preventive Services Task Force's new breast cancer screening guidelines, but prospects for longer-term adjustments remain
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.